Cited by 2,489Cardiac electrophysiology and arrhythmiasCardiac pacing and defibrillation studiesCardiac Arrhythmias and Treatments

The DOI matches its Crossref record, with a small difference in title or year; 34 of the 34 references it cites were found in a registry or an index.

A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease

Open access

Buxton, Alfred E., Lee, Kerry L., Fisher, John D., Josephson, Mark E., Prystowsky, Eric N., Hafley, Gail·1999·New England Journal of Medicine

DOI 10.1056/nejm199912163412503

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Empirical antiarrhythmic therapy has not reduced mortality among patients with coronary artery disease and asymptomatic ventricular arrhythmias. Previous studies have suggested that antiarrhythmic therapy guided by electrophysiologic testing might reduce the risk of sudden death. METHODS: We conducted a randomized, controlled trial to test the hypothesis that electrophysiologically guided antiarrhythmic therapy would reduce the risk of sudden death among patients with coronary artery disease, a left ventricular ejection fraction of 40 percent or less, and asymptomatic, unsustained ventricular tachycardia. Patients in whom sustained ventricular tachyarrhythmias were induced by programmed stimulation were randomly assigned to receive either antiarrhythmic therapy, including drugs and implantable defibrillators, as indicated by the results of electrophysiologic testing, or no antiarrhythmic therapy. Angiotensin-converting-enzyme inhibitors and beta-adrenergic-blocking agents were administered if the patients could tolerate them. RESULTS: A total of 704 patients with inducible, sustained ventricular tachyarrhythmias were randomly assigned to treatment groups. Five-year Kaplan-Meier estimates of the incidence of the primary end point of cardiac arrest or death from arrhythmia were 25 percent among those receiving electrophysiologically guided therapy and 32 percent among the patients assigned to no antiarrhythmic therapy (relative risk, 0.73; 95 percent confidence interval, 0.53 to 0.99), representing a reduction in risk of 27 percent). The five-year estimates of overall mortality were 42 percent and 48 percent, respectively (relative risk, 0.80; 95 percent confidence interval, 0.64 to 1.01). The risk of cardiac arrest or death from arrhythmia among the patients who received treatment with defibrillators was significantly lower than that among the patients discharged without receiving defibrillator treatment (relative risk, 0.24; 95 percent confidence interval, 0.13 to 0.45; P<0.001). Neither the rate of cardiac arrest or death from arrhythmia nor the overall mortality rate was lower among the patients assigned to electrophysiologically guided therapy and treated with antiarrhythmic drugs than among the patients assigned to no antiarrhythmic therapy. CONCLUSIONS: Electrophysiologically guided antiarrhythmic therapy with implantable defibrillators, but not with antiarrhythmic drugs, reduces the risk of sudden death in high-risk patients with coronary disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199912163412503

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,244
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
The AVID Investigators (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,221
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT
Julian, D. G., CAMM, A. J., Frangin, G., Janse, M. J., Munoz, A., Pj, S., & Simon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09145-3 · Cited by 1,100

Show all 34 references

Research works printed but not linked: 1

10.2307/2281868 · DOI · Paper page

Sorted by citations

2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
“symptoms while receiving GDMT, who have reasonable expectation of meaningful survival for more than 1 yeary (362,597,598).”
Background
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
Moss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
Dickstein, K., Authors Task Force Members, Solal, A. C., Filippatos, G. S., McMurray, J. J. V., Ponikowski, P. P., Poole-Wilson, P. A., Strömberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.08.005 · Cited by 3,532
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Zeppenfeld, K., Tfelt‐Hansen, J., Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,432
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Authors Task Force Members, Dickstein, K., Solal, A. C., Filippatos, G., McMurray, J. J. V., Ponikowski, P. P., Poole-Wilson, P. A., Strömberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn309 · Cited by 2,705
ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities
Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.032 · Cited by 2,546
Part 9: Post–Cardiac Arrest Care
Peberdy, M. A., Callaway, C. W., Neumar, R. W., Geocadin, R. G., Zimmerman, J. L., Donnino, M. W., Gabrielli, A., Silvers, S. M., ZARITSKY, A. L., Merchant, R. M., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.971002 · Cited by 2,537
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation
Authors Task Force Members, de Werf, F. V., Bax, J. J., Betriu, A., Blomström‐Lundqvist, C., Crea, F., Falk, V., Filippatos, G. S., Fox, K. A. A., Huber, K., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn416 · Cited by 2,309
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
Swedberg, K. B., Cleland, J. G. F., Dargie, H., Drexler, H., Folláth, F., Michel Komajda, N., Tavazzi, L., Smiseth, O. A., Gavazzi, A., Haverich, A., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi204 · Cited by 2,257
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,213
“symptoms while receiving GDMT, who have reasonable expectation of meaningful survival for more than 1 yeary (362,597,598).”
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
Kadish, A. H., Dyer, A. R., Daubert, J. P., Quigg, R. J., Estes, N. A. M., Anderson, K. P., Calkins, H. G., Hoch, D., Goldberger, J. J., Shalaby, A. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033088 · Cited by 2,078
Dual-Chamber Pacing or Ventricular Backup Pacing in Patients With an Implantable Defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial
The DAVID Trial Investigators* (2002) · JAMA · doi:10.1001/jama.288.24.3115 · Cited by 2,056
PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION
Oss, J. M., Areba, W. O. Z., Ackson, W. J., Lein, H. E. K., Ilber, D. A. J. W., Annom, D. A. S. C., Ames, J. M., Aubert, P., Iggins, S. T. L. H., Rown, M. A. W. B., et al. (2002) · Cited by 2,026
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,973
Self-citation
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,902
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
Epstein, A. E., Dimarco, J., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Circulation · doi:10.1161/circualtionaha.108.189742 · Cited by 1,772
Defibrillator implantation in patients with nonischemic systolic heart failure
Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., Jensen, G., Hildebrandt, P., Steffensen, F. H., Bruun, N. E., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1608029 · Cited by 1,763
Guidelines for the diagnosis and treatment of chronic heart failure
Remme, W. J. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2783 · Cited by 1,593
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
Maron, B. J., McKenna, W. J., Danielson, G. K., KAPPENBERGER, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,572
Acute myocardial infarction
Reed, G. W., Rossi, J., & Cannon, C. P. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30677-8 · Cited by 1,614
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
Epstein, A. E., Dimarco, J., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e318276ce9b · Cited by 1,496
Sudden Death Due to Cardiac Arrhythmias
Huikuri, H. V., Castellanos, A., & Myerburg, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmra000650 · Cited by 1,490
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention
Goldberger, J. J., Cain, M. E., Hohnloser, S. H., Kadish, A. H., Knight, B. P., Lauer, M. S., Maron, B. J., Page, R. L., Passman, R. S., Siscovick, D., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.189375 · Cited by 1,450
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
(2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.01.019 · Cited by 1,439
HFSA 2010 Comprehensive Heart Failure Practice Guideline
Heart Failure Society of America (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.04.004 · Cited by 1,301
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article
Gregoratos, G., Abrams, J., Epstein, A. E., Freedman, R. A., Hayes, D. L., Hlatky, M. A., Kerber, R. E., Naccarelli, G. V., Schoenfeld, M. H., Silka, M. J., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02528-7 · Cited by 1,273
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.178233 · Cited by 1,080
Self-citation
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article
Gregoratos, G., Abrams, J., Epstein, A. E., Freedman, R. A., Hayes, D. L., Hlatky, M. A., Kerber, R. E., Naccarelli, G. V., Schoenfeld, M. H., Silka, M. J., et al. (2002) · Circulation · doi:10.1161/01.cir.0000035996.46455.09 · Cited by 907
Task Force on Sudden Cardiac Death of the European Society of Cardiology
Priori, S. G. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2824 · Cited by 898
Guidelines for cardiac pacing and cardiac resynchronization therapy
Vardas, P. E., Auricchio, A., Blanc, J., Daubert, J., Drexler, H., Ector, H., Gasparini, M., Linde, C. M., Morgado, F. B., Oto, A., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm305 · Cited by 895
Differences in Tachyarrhythmia Detection and Implantable Cardioverter Defibrillator Therapy by Primary or Secondary Prevention Indication in Cardiac Resynchronization Therapy Patients
Wilkoff, B. L., HESS, M., Young, J. B., & Abraham, W. T. (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.03625.x · Cited by 832
Inappropriate Implantable Cardioverter-Defibrillator Shocks in MADIT II
Daubert, J. P., Zaręba, W., Cannom, D. S., McNitt, S. A., Rosero, S. Z., Wang, P. J., Schuger, C. D., Steinberg, J. S., Higgins, S. L., Wilber, D. J., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.073 · Cited by 810
Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both
Solomon, S. D., Zelenkofske, S., McMurray, J. J. V., Finn, P. V., Velazquez, E. J., Ertl, G., Harsanyi, A., Rouleau, J. L., Maggioni, A. P., Køber, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043938 · Cited by 800
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Moss, A. J., Myerburg, R. J., et al. (2006) · EP Europace · doi:10.1093/europace/eul108 · Cited by 740
“ICD therapy is indicated to reduce the risk of SCD in 2 patient groups: patients whose LVEF is less than or equal to 40% as a result of prior MI and who have spontaneous NSVT and sustained monomorphic VT inducible by EP testing (50) and patients whose LVEF is less than 30% as a result of an MI that occurred greater th…”
BackgroundResultSelf-citation
Mechanistic Pathways of Sex Differences in Cardiovascular Disease
Regitz‐Zagrosek, V., & Kararigas, G. (2016) · Physiological Reviews · doi:10.1152/physrev.00021.2015 · Cited by 758
“On the other hand, ventricular arrhythmias and sudden cardiac death are more common in men than in women, and male sex is a strong predictor of risk for atrial fibrillation (6, 14, 28, 50, 180).”
Background
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
Tracy, C. M., Epstein, A. E., Darbar, D., Dimarco, J., Dunbar, S. B., Estes, N. A. M., Ferguson, T. B., Hammill, S. C., Karasik, P., Link, M. S., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.007 · Cited by 748
Epidemiology of Sudden Cardiac Death: Clinical and Research Implications
Chugh, S. S., Reinier, K., Teodorescu, C., Evanado, A., Kehr, E. L., Samara, M. A., Mariani, R., Gunson, K., & Jui, J. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.06.003 · Cited by 732
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000549 · Cited by 771
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.035 · Cited by 743
The Spectrum of Epidemiology Underlying Sudden Cardiac Death
Hayashi, M., Shimizu, W., & Albert, C. M. (2015) · Circulation Research · doi:10.1161/circresaha.116.304521 · Cited by 741
“To date, only inducible sustained VT at electrophysiology study has been proven in a randomized clinical trial to identify individuals at a higher risk of SCA versus non-SCA.(171) However, the sensitivity of this test in isolation is inadequate to guide ICD therapy, especially in patients with LVEF <30%.”
Cardiac Resynchronization and Death From Progressive Heart Failure
Bradley, D. J., Bradley, E. A., Baughman, K. L., Berger, R. D., Calkins, H. G., Goodman, S. N., Kass, D. A., & Powe, N. R. (2003) · JAMA · doi:10.1001/jama.289.6.730 · Cited by 707
JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure ― Digest Version ―
Tsutsui, H., Isobe, M., Ito, H., Ito, H., Okumura, K., Ōno, M., Kitakaze, M., Kinugawa, K., Kihara, Y., Goto, Y., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0342 · Cited by 711
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
Maron, B. J., McKenna, W. J., Danielson, G. K., Kappenberger, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., ten Cate, F. J., et al. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00479-2 · Cited by 698
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.053 · Cited by 689
Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy
Bänsch, D., Antz, M., Boczor, S., Volkmer, M., Tebbenjohanns, J., Seidl, K., Block, M. S., Gietzen, F. H., Berger, J., & Kück, K. (2002) · Circulation · doi:10.1161/01.cir.0000012350.99718.ad · Cited by 644
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.036 · Cited by 644
Part 8: Advanced Life Support
Morrison, L. J., Deakin, C. D., Morley, P. T., Callaway, C. W., Kerber, R. E., Kronick, S. L., Lavonas, E. J., Link, M. S., Neumar, R. W., Otto, C. W., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.971051 · Cited by 615
Acute myocardial infarction
White, H. D., & Chew, D. P. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61237-4 · Cited by 619
Sudden Cardiac Death Prediction and Prevention
Fishman, G. I., Chugh, S. S., Dimarco, J., Albert, C. M., Anderson, M. E., Bonow, R. O., Buxton, A. E., Chen, P., Estes, M., Jouven, X., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.976092 · Cited by 633
Self-citation
Up-to-date catalogues of yeast protein complexes
Pu, S., Wong, J., Turner, B., Cho, E., & Wodak, S. J. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn1005 · Cited by 598
Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator
Moss, A. J., Greenberg, H., Case, R. B., Zaręba, W., Hall, W. J., Brown, M. W., Daubert, J. P., McNitt, S. A., Andrews, M. L., & Elkin, A. D. (2004) · Circulation · doi:10.1161/01.cir.0000150390.04704.b7 · Cited by 599
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Rao, S. V., O’Donoghue, M. L., Ruel, M., Rab, T., Tamis-Holland, J. E., Alexander, J. H., Baber, U., Baker, H., Cohen, M. G., Cruz-Ruiz, M., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001309 · Cited by 625
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
Rao, S. V., O’Donoghue, M. L., Ruel, M., Rab, T., Tamis-Holland, J. E., Alexander, J. H., Baber, U., Baker, H., Cohen, M. G., Cruz-Ruiz, M., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.11.009 · Cited by 668
Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemicdilated cardiomyopathy and asymptomaticnonsustained ventricular tachycardia—AMIOVIRT
Strickberger, S. A., Hummel, J. D., Bartlett, T. G., Frumin, H., Schuger, C. D., Beau, S. L., Bitar, C., & Morady, F. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00297-3 · Cited by 586
Electrophysiologic Testing to Identify Patients with Coronary Artery Disease Who Are at Risk for Sudden Death
Buxton, A. E., Lee, K. L., DiCarlo, L. A., Gold, M. R., Greer, G. S., Prystowsky, E. N., O’Toole, M. F., TANG, A. S. L., Fisher, J. D., Coromilas, J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422602 · Cited by 564
Self-citation
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
Epstein, A. E., Dimarco, J., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.04.014 · Cited by 550
“ABBREVIATIONS LIST CC American College of Cardiology CCF American College of Cardiology Foundation F Atrial fibrillation HA American Heart Association MI Acute myocardial infarction MIOVIRT Amiodarone Versus Implantable Defibrillator in Patients with Nonischemic Cardiomyopathy and Asymptomatic Nonsustained Ventricular…”
MethodInfluential
Cost-Effectiveness of Implantable Cardioverter–Defibrillators
Sanders, G. D., Hlatky, M. A., & Owens, D. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa051989 · Cited by 543
Population-Based Analysis of Sudden Cardiac Death With and Without Left Ventricular Systolic Dysfunction
Stecker, E. C., Vickers, C. A., Waltz, J., Socoteanu, C., John, B. T., Mariani, R., McAnulty, J. H., Gunson, K., Jui, J., & Chugh, S. S. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.045 · Cited by 540
Preventing ventricular fibrillation by flattening cardiac restitution
Garfinkel, A., Kim, Y., Voroshilovsky, O., Qu, Z., Kil, J. R., Lee, M., Karagueuzian, H. S., Weiss, J. N., & Chen, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090492697 · Cited by 531
Risk Stratification for Primary Implantation of a Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction
Goldenberg, I., Vyas, A. K., Hall, W. J., Moss, A. J., Wang, H., He, H., Zaręba, W., McNitt, S. A., & Andrews, M. L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.08.058 · Cited by 530
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death—executive summary
Zipes, D. P., Camm, A. J., Borggrefe, M. M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Moss, A. J., Myerburg, R. J., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl199 · Cited by 519
Self-citation
Infarct morphology identifies patients with substrate for sustained ventricular tachycardia
Bello, D. B., Fieno, D. S., Kim, R. J., Pereles, F. S., PASSMAN, R. S., Song, G. K., Kadish, A. H., & Goldberger, J. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.057 · Cited by 471
Body Mass Index and Risk, Age of Onset, and Survival in Patients With Pancreatic Cancer
Li, D. (2009) · JAMA · doi:10.1001/jama.2009.886 · Cited by 474
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary
Epstein, A. E., Dimarco, J., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.04.015 · Cited by 462
“Abbreviations List ACC American College of Cardiology ACCF American College of Cardiology Foundation AHA American Heart Association AV Atrioventricular CRT Cardiac resynchronization therapy DDD Dual-chamber pacemaker that senses/paces in the atrium/ventricle and is inhibited/triggered by intrinsic rhythm LVEF Left ven…”
Inappropriate Implantable Cardioverter-Defibrillator Shocks
van Rees, J. B., Borleffs, C. J. W., de Bie, M. K., Stijnen, T., van Erven, L., Bax, J. J., & Schalij, M. J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.059 · Cited by 449
Prescribing Amiodarone
Vassallo, P., & Trohman, R. G. (2007) · JAMA · doi:10.1001/jama.298.11.1312 · Cited by 449
Value of Programmed Ventricular Stimulation After Tetralogy of Fallot Repair
Khairy, P., Landzberg, M. J., Gatzoulis, M. Α., Lucron, H., Lambert, J., Marçon, F., Alexander, M. E., & Walsh, E. P. (2004) · Circulation · doi:10.1161/01.cir.0000126495.11040.bd · Cited by 435
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes
Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., & Stevenson, W. G. (2006) · Circulation · doi:10.1161/circulationaha.106.655688 · Cited by 455
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
Goldberger, J. J., CAIN, M. E., Hohnloser, S. H., Kadish, A. H., Knight, B. P., Lauer, M. S., Maron, B. J., Page, R. L., PASSMAN, R. S., Siscovick, D. S., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.003 · Cited by 432
Significance of QRS Complex Duration in Patients With Heart Failure
Kashani, A., & Barold, S. S. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.071 · Cited by 422
Sex and Racial Differences in the Use of Implantable Cardioverter-Defibrillators Among Patients Hospitalized With Heart Failure
Hernandez, A. F., Fonarow, G. C., Liang, L., Al‐Khatib, S. M., Curtis, L. H., LaBresh, K. A., Yancy, C. W., Albert, N. M., & Peterson, E. D. (2007) · JAMA · doi:10.1001/jama.298.13.1525 · Cited by 419
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000548 · Cited by 412
QRS duration and mortality in patients with congestive heart failure
Iuliano, S., Fisher, S. G., Karasik, P., Fletcher, R. D., & Singh, S. N. (2002) · American Heart Journal · doi:10.1067/mhj.2002.122516 · Cited by 403
Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy
Desai, A. S., Fang, J. C., Maisel, W. H., & Baughman, K. L. (2004) · JAMA · doi:10.1001/jama.292.23.2874 · Cited by 403
Navigating the Crossroads of Coronary Artery Disease and Heart Failure
Gheorghiade, M., Sopko, G. S., Luca, L. D., Velazquez, E. J., Parker, J. D., Binkley, P. F., Sadowski, Z., Golba, K. S., Prior, D., Rouleau, J. L., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.623199 · Cited by 405
Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement
Brugada, J., Blom, N. A., Sarquella‐Brugada, G., Blomström‐Lundqvist, C., Deanfield, J. E., Janoušek, J., Abrams, D. J., Bauersfeld, U., Brugada, R., Drago, F., et al. (2013) · EP Europace · doi:10.1093/europace/eut082 · Cited by 397
“– 301 Large randomized primary prevention trials in adults with heart failure also showed a survival benefit from ICD implantation.(292) – 294 Guidelines for primary prevention in children and CHD patients (see below) are currently in a rudimentary state due to the absence of any randomized trials or large observation…”
Background
Results of a Multicenter Retrospective Implantable Cardioverter-Defibrillator Registry of Pediatric and Congenital Heart Disease Patients
Berul, C. I., Hare, G. F. V., Kertesz, N. J., Dubin, A. M., Cecchin, F., Collins, K. K., Cannon, B. C., Alexander, M. E., Triedman, J. K., Walsh, E. P., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.01.033 · Cited by 398
Electrical Storm Presages Nonsudden Death
Exner, D. V., Pinski, S. L., Wyse, D. G., Renfroe, E. G., Follmann, D. A., Gold, M. R., Beckman, K. J., Coromilas, J., Lancaster, S. E., & Hallstrom, A. P. (2001) · Circulation · doi:10.1161/01.cir.103.16.2066 · Cited by 390
Increasing rates of cardiac device infections among medicare beneficiaries: 1990–1999
Cabell, C. H., Heidenreich, P. A., Chu, V. H. Y., Moore, C. M., Stryjewski, M. E., Corey, G. R., & Fowler, V. G. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.06.005 · Cited by 393
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary
Epstein, A. E., Dimarco, J., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Circulation · doi:10.1161/circualtionaha.108.189741 · Cited by 366
Percent right ventricular pacing predicts outcomes in the DAVID trial
Sharma, A. D., Rizo-Patrón, C., Hallstrom, A. P., O’Neill, G., Rothbart, S. T., Martins, J. B., Roelke, M., Steinberg, J. S., & Greene, H. L. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.05.015 · Cited by 365
Analysis of mortality events in the multicenter automatic defibrillator implantation trial (MADIT-II)
Greenberg, H., Case, R. B., Moss, A. J., Brown, M. W., Carroll, E. R., & Andrews, M. L. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.038 · Cited by 361
“We and others have used the Hinkle-Thaler approach for lassifying SCDs subcategorized by the degree of LV dysfuncion (1,2,5).”
BackgroundMethod
A Critical Appraisal of Implantable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death
Tung, R. H., ZIMETBAUM, P. J., & Josephson, M. E. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.058 · Cited by 360
Self-citation
Limitations of Ejection Fraction for Prediction of Sudden Death Risk in Patients With Coronary Artery Disease
Buxton, A. E., Lee, K. L., Hafley, G. E., Pires, L. A., Fisher, J. D., Gold, M. R., Josephson, M. E., Lehmann, M. H., & Prystowsky, E. N. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.095 · Cited by 356
Self-citation
T-Wave Alternans and the Susceptibility to Ventricular Arrhythmias
Narayan, S. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.066 · Cited by 358
ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy
Russo, A. M., Stainback, R. F., Bailey, S. R., Epstein, A. E., Heidenreich, P. A., Jessup, M. L., Kapa, S., Kremers, M. S., Lindsay, B. D., & Stevenson, L. W. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.01.008 · Cited by 348
ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy
Russo, A. M., Stainback, R. F., Bailey, S. R., Epstein, A. E., Heidenreich, P. A., Jessup, M. L., Kapa, S., Kremers, M. S., Lindsay, B. D., & Stevenson, L. W. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.12.017 · Cited by 348
Heart failure management using implantable devices for ventricular resynchronization: Comparison of medical therapy, pacing, and defibrillation in chronic heart failure (COMPANION) trial
Bristow, M. R., Feldman, A. M., & Saxon, L. A. (2000) · Journal of Cardiac Failure · doi:10.1054/jcaf.2000.9501 · Cited by 328
2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry
Steinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P., Balsam, P., Baranchuk, A., Cantillon, D. J., Dilaveris, P., Dubner, S. J., El-Sherif, N., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.038 · Cited by 303
“Following the Multicenter Unsustained Tachycardia Trial (MUSTT) (Buxton et al., 1999), there is a role for AECG for NSVT detection in post-MI patients with LVEF 35%–40% as electrophysiologically guided ICD implantation improves survival (Epstein et al.”
BackgroundMethod
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing
Wilkoff, B. L., Fauchier, L., Stiles, M. K., Morillo, C. A., Al-Khatib, S. M., Almendral, J., Aguinaga, L., Berger, R. D., Cuesta, A., Daubert, J. P., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2015.11.018 · Cited by 301
Sudden Cardiac Death: Exploring the Limits of Our Knowledge
Myerburg, R. J. (2001) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2001.00369.x · Cited by 296
Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society
Linde, C. M., Bongiorni, M. G., Birgersdotter-Green, U. M., Curtis, A. B., Deisenhofer, I., Furokawa, T., Gillis, A. M., Haugaa, K. H., Lip, G. Y. H., Gelder, I. C. V., et al. (2018) · EP Europace · doi:10.1093/europace/euy067 · Cited by 308
NON‐CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Sudden Cardiac Death and Dialysis Patients
Herzog, C. A., Mangrum, J. M., & PASSMAN, R. S. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2008.00455.x · Cited by 290
Implantable Cardioverter–Defibrillators
Dimarco, J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035432 · Cited by 294
Guidelines for cardiac pacing and cardiac resynchronization therapy
Vardas, P. E., Auricchio, A., Blanc, J., Daubert, J., Drexler, H., Ector, H., Gasparini, M., Linde, C. M., Morgado, F. B., Oto, A., et al. (2007) · EP Europace · doi:10.1093/europace/eum189 · Cited by 290
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.020 · Cited by 297
Wearable Cardioverter–Defibrillator after Myocardial Infarction
Olgin, J. E., Pletcher, M. J., Vittinghoff, E., Wranicz, J. K., Malik, R. K., Morin, D. P., ZWEIBEL, S. L., Buxton, A. E., Elayi, C. S., Chung, E. H., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800781 · Cited by 288
Self-citation

Authors: Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G.
Affiliations: Brown University (US)
Duke University (US)
Albert Einstein College of Medicine (US)
Beth Israel Deaconess Medical Center (US)
ORCID: Buxton, Alfred E.
Lee, Kerry L.
Fisher, John D.
Prystowsky, Eric N.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1999-12-16
Volume: 341
Issue: 25
Pages: 1882-1890
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199912163412503
OpenAlex: W2313547185
Cited by: 2,489
References: 34
Citations by year: 2026: 20 · 2025: 36 · 2024: 23 · 2023: 34 · 2022: 44 · 2021: 41 · 2020: 51 · 2019: 54 · 2018: 54 · 2017: 92 · 2016: 75 · 2015: 87 · 2014: 95 · 2013: 114 · 2012: 122
FWCI: 70.29
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5u01hl045726-06)
National Heart, Lung, and Blood Institute (UO1HL45700, UO1-HL45726, U01HL045700)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Keywords: coronary artery disease, asymptomatic ventricular arrhythmia, implantable cardioverter-defibrillator, antiarrhythmic drugs, electrophysiologic testing, programmed electrical stimulation, cardiac arrest, all-cause mortality, left ventricular ejection fraction, ACE inhibitors, beta-blockers
MeSH terms: Aged, Anti-Arrhythmia Agents, Cardiac Pacing, Artificial, Coronary Disease, Electrophysiology, Female, Humans, Male, Middle Aged, Survival Analysis, Death, Sudden, Cardiac, Defibrillators, Implantable, Tachycardia, Ventricular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks